Erectile Dysfunction Devices Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Erectile Dysfunction Devices Market with other markets in Healthcare Industry

Erectile Dysfunction Devices Market Analysis by Mordor Intelligence

The erectile dysfunction devices market is valued at USD 1.88 billion in 2025 and is forecast to advance to USD 2.95 billion by 2030, registering a 9.40% CAGR during the period. Rising dissatisfaction with oral phosphodiesterase-5 inhibitors, which show more than 40% real-world non-response, accelerates patient migration toward mechanical or implantable therapies. Device makers are also benefiting from younger-onset prevalence trends, expanded post-prostatectomy protocols, and streamlined tele-prescription rules that support at-home therapy initiation. Concurrently, hospital cost-containment imperatives push outpatient centers to adopt minimally invasive techniques, improving operating margins for providers while preserving quality outcomes. On the supply side, manufacturers are re-engineering bill-of-materials to reduce exposure to silicone shortages and to comply with new vacuum device pressure-range coding, strengthening production resilience.

Key Report Takeaways

  • By device type, penile implants led with 52.35% of erectile dysfunction devices market share in 2024, whereas low-intensity shockwave systems are projected to expand at a 12.25% CAGR through 2030.
  • By cause, vascular disorders accounted for 60.53% share of the erectile dysfunction devices market size in 2024; neurological causes show the highest forecast CAGR at 10.85% to 2030.
  • By end user, hospitals commanded 46.82% of 2024 revenue, but ambulatory surgery centers are advancing at a 10.61% CAGR through 2030.
  • By geography, North America captured 41.82% of 2024 revenue, while Asia-Pacific is on track for an 11.52% CAGR through 2030.

Segment Analysis

By Device Type: Implants Lead Innovation Wave

Penile implants retained 52.35% revenue in 2024 and generated the majority of the erectile dysfunction devices market size attributed to surgical solutions. The latest AMS 700 with TENACIO pump shortens inflation cycles and delivers 10-year durability, features that pushed 2025 unit demand up by double digits in U.S. centers. Such improvements signal why implants still dominate a crowded field of vacuums, wearables, and shockwave consoles. Growth, however, now tilts toward non-invasive categories: low-intensity shockwave platforms logged a 12.25% CAGR and are popular in multidisciplinary men’s-health clinics where physicians package the therapy with platelet-rich plasma injections to lift response rates[3]Rajesh Kumar et al., “Low-Intensity Shockwave Therapy Long-Term Outcomes,” PubMed Central, pmc.ncbi.nlm.nih.gov.

Vacuum constriction cylinders, newly coded under 2025 HCPCS guidelines, enjoy reimbursement clarity that widens payer coverage. Wearables such as Eddie by Giddy achieved FDA registration and posted 88.9% pain-free intercourse scores in a 2024 survey, crowding the niche for mild-to-moderate cases. These varied modalities collectively ensure that the erectile dysfunction devices market remains technologically pluralistic.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Cause of Dysfunction: Vascular Dominance Drives Innovation

In 2024, vascular etiologies represented 60.53% of therapy volume, underscoring cardiovascular comorbidity as the prime target of emerging gadgets. Shockwave consoles promote neovascularization and yielded a 69% minimal clinically important difference in African trial cohorts three months post-treatment. The erectile dysfunction devices market size for vascular cases will deepen as diabetic and hypertensive patients flow into care pathways. Meanwhile, neurological causes are expanding at 10.85% CAGR, owing to post-COVID neuropathies that lengthen waitlists for specialized neuro-urology consults.

PNAS-reported microrobot technology, which ferries mesenchymal stromal cells directly into cavernous tissue, promises a regenerative alternative that could disrupt vascular and neurogenic treatment algorithms. Psychogenic categories also benefit from AI-assisted decision tools that elevate diagnostic accuracy, guiding clinicians toward bespoke device selections.

By End User: Ambulatory Centers Accelerate Growth

Hospitals accounted for 46.82% revenue in 2024, yet the shift to outpatient settings is unmistakable. Minimally invasive infrapubic approaches reduced infection rates to 0% in straightforward cases, enabling same-day discharge and catalyzing a 10.61% CAGR for ambulatory surgery centers. Clinics and physician-owned offices ride the telehealth wave by bundling vacuum or shockwave packages with virtual follow-up, giving them a cost edge relative to tertiary hospitals. Such dynamics realign value capture within the erectile dysfunction devices market, rewarding providers that can compress operating time while sustaining outcomes.

Erectile Dysfunction Devices Market: Market Share by End User
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Geography Analysis

North America remains the fulcrum of revenue, holding 41.82% in 2024 on the back of robust payer frameworks and an installed base of high-volume urologists. Boston Scientific’s interventional urology sales hit USD 633 million in Q1 2025, with erectile prostheses a core component. The region’s clinicians increasingly bypass staged prosthesis-sphincter surgeries, further expanding procedure counts.

Asia-Pacific, however, is the fastest climber at 11.52% CAGR. Japanese retrospective studies validate next-gen vacuums, while China’s domestic producers of silicone reservoirs shrink import reliance. Medical tourism to Turkey, where Coloplast Titan procedures average EUR 10,000, attracts European and Middle Eastern patients seeking price relief. Together, these dynamics are enlarging regional slices of the erectile dysfunction devices market.

Europe exhibits mid-single-digit growth as MDR roll-outs stabilize and payer reviews temper shockwave reimbursements. Key markets such as Germany still fund implants for severe cases, sustaining baseline demand. Latin America and the Middle East are in earlier adoption cycles but benefit from improving cultural openness and international provider partnerships, positioning them as long-term contributors.

Erectile Dysfunction Devices Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The erectile dysfunction devices industry shows moderate concentration. Boston Scientific, Coloplast, and Rigicon control majority of implant unit shipments yet face insurgent wearable and shockwave entrants. Boston Scientific’s USD 3.7 billion acquisition of Axonics broadens its pelvic health continuum, allowing cross-selling into overactive bladder and fecal incontinence pathways. Coloplast’s Titan line secured 5% growth in FY 2024 despite raw-material inflationary pressure that squeezed margins.

Rigicon differentiates through complex-case ergonomics and collagen fleece grafting techniques that restore curvature, earning surgeon loyalty in tertiary referral centers. Start-ups like Ohh-Med and Reach Medical chase non-invasive niches with upgraded wearables and rechargeable vacuums, both benefiting from direct-to-consumer channels. Supply-chain continuity emerges as a battleground; firms investing in dual-source silicone molding or additive-manufactured reservoirs incur lower back-order risk during global shortages.

Erectile Dysfunction Devices Industry Leaders

  1. Coloplast Group

  2. Rigicon, Inc.

  3. Boston Scientific Corporation

  4. Promedon GmBH

  5. Zephyr Surgical Implants

  6. *Disclaimer: Major Players sorted in no particular order
Erectile Dysfunction Devices Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • November 2024: Boston Scientific launches the TENACIO pump as part of its AMS 700 IPP system, offering a 27% faster refill and independent valve action.
  • June 2024: Ohh-Med unveils an ergonomically enhanced wearable erectile dysfunction device to improve user comfort.

Table of Contents for Erectile Dysfunction Devices Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Prevalence Of Erectile Dysfunction
    • 4.2.2 Increasing Post-Prostatectomy Rehabilitation Demand
    • 4.2.3 Rise In R&D And FDA Approvals For Next-Gen ED Devices
    • 4.2.4 High Dissatisfaction With Oral ED Drugs Fuels Device Uptake
    • 4.2.5 Tele-Prescription Laws Enable At-Home VED Adoption
    • 4.2.6 Mini-Incision IPP Techniques Cut Cost & LOS
  • 4.3 Market Restraints
    • 4.3.1 Availability Of Pharmacologic Alternatives
    • 4.3.2 Social Stigma & Low Patient Awareness
    • 4.3.3 Supply-Chain Fragility In Medical-Grade Silicone Components
    • 4.3.4 Reimbursement Downgrades For Shockwave Therapy In US/EU
  • 4.4 Porter's Five Forces
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Device Type
    • 5.1.1 Penile Implants
    • 5.1.2 Vacuum Constriction Devices (VED)
    • 5.1.3 Shockwave Therapy Systems
    • 5.1.4 Other Device Types
  • 5.2 By Cause of Dysfunction
    • 5.2.1 Vascular Disorder
    • 5.2.2 Neurological Disorder
    • 5.2.3 Other Causes
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Clinics & Specialty Centers
    • 5.3.3 Ambulatory Surgery Centers
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 South Korea
    • 5.4.3.5 Australia
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.3.1 Augusta Medical Systems
    • 6.3.2 Boston Scientific Corporation
    • 6.3.3 Coloplast Group
    • 6.3.4 Medispec Ltd.
    • 6.3.5 Owen Mumford Limited
    • 6.3.6 Promedon GmbH
    • 6.3.7 Rigicon Inc.
    • 6.3.8 Shenzhen Huikang Medical Apparatus
    • 6.3.9 Zephyr Surgical Implants
    • 6.3.10 Zimmer Medizinsysteme GmbH
    • 6.3.11 Timm Medical Technologies
    • 6.3.12 Encore (Therapeutics Inc.)
    • 6.3.13 Direx Group
    • 6.3.14 Ohh-Med Medical
    • 6.3.15 Phoenix Pro (Launch Medical)
    • 6.3.16 Lumsail Industrial
    • 6.3.17 EDCure (Endo Tech)
    • 6.3.18 Zealand Medical
    • 6.3.19 Cynosure LLC
    • 6.3.20 Alma Lasers

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Erectile Dysfunction Devices Market Report Scope

As per the scope of the report, erectile dysfunction devices are medical tools designed to help men achieve and maintain an erection. These devices can either be surgically implanted or are external pumps that create a vacuum around the penis. The erectile dysfunction devices market is segmented by device type, cause of the dysfunction, end user and geography. The device type segment is further divided into penile implants, vacuum constriction devices, shockwave therapy, and other device types. The cause of the dysfunction segment is further segmented into vascular disorders, neurological disorders, and other causes. The End User segment is further bifurcated into hospitals, clinics, and ambulatory surgical centers. The geography segment is further bifurcated into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report offers the value (in USD) for the above segments.

By Device Type Penile Implants
Vacuum Constriction Devices (VED)
Shockwave Therapy Systems
Other Device Types
By Cause of Dysfunction Vascular Disorder
Neurological Disorder
Other Causes
By End User Hospitals
Clinics & Specialty Centers
Ambulatory Surgery Centers
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
By Device Type
Penile Implants
Vacuum Constriction Devices (VED)
Shockwave Therapy Systems
Other Device Types
By Cause of Dysfunction
Vascular Disorder
Neurological Disorder
Other Causes
By End User
Hospitals
Clinics & Specialty Centers
Ambulatory Surgery Centers
Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the growth rate of the erectile dysfunction devices market from 2025 to 2030?

The market is projected to expand at a 9.40% CAGR, climbing from USD 1.88 billion in 2025 to USD 2.95 billion in 2030.

Which device type currently holds the largest market share?

Penile implants lead with 52.35% of 2024 revenue, buoyed by innovations such as Boston Scientific’s TENACIO pump.

Which region is expected to grow the fastest through 2030?

Asia-Pacific is forecast to post the highest regional CAGR at 11.52%, driven by stronger healthcare infrastructure and diminishing cultural barriers.

Why are more patients moving from oral ED drugs to devices?

Around 40% of users do not respond adequately to PDE5 inhibitors and face rising out-of-pocket costs, so many shift to mechanical or implantable options for reliable results.

What fuels the rapid growth of ambulatory surgery centers in this market?

Mini-incision and no-touch implant techniques enable same-day discharge, propelling ambulatory centers to a 10.61% CAGR as procedures migrate from hospitals.

Page last updated on: